Structure

Physi-Chem Properties

Molecular Weight:  498.37
Volume:  546.497
LogP:  5.341
LogD:  5.047
LogS:  -4.754
# Rotatable Bonds:  4
TPSA:  63.6
# H-Bond Aceptor:  4
# H-Bond Donor:  1
# Rings:  5
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.32
Synthetic Accessibility Score:  4.879
Fsp3:  0.875
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.248
MDCK Permeability:  8.249463280662894e-05
Pgp-inhibitor:  0.005
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.004
20% Bioavailability (F20%):  0.009
30% Bioavailability (F30%):  0.683

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.007
Plasma Protein Binding (PPB):  91.5213851928711%
Volume Distribution (VD):  0.886
Pgp-substrate:  2.343862771987915%

ADMET: Metabolism

CYP1A2-inhibitor:  0.015
CYP1A2-substrate:  0.466
CYP2C19-inhibitor:  0.022
CYP2C19-substrate:  0.947
CYP2C9-inhibitor:  0.133
CYP2C9-substrate:  0.759
CYP2D6-inhibitor:  0.005
CYP2D6-substrate:  0.354
CYP3A4-inhibitor:  0.218
CYP3A4-substrate:  0.284

ADMET: Excretion

Clearance (CL):  1.948
Half-life (T1/2):  0.337

ADMET: Toxicity

hERG Blockers:  0.121
Human Hepatotoxicity (H-HT):  0.163
Drug-inuced Liver Injury (DILI):  0.022
AMES Toxicity:  0.001
Rat Oral Acute Toxicity:  0.019
Maximum Recommended Daily Dose:  0.149
Skin Sensitization:  0.854
Carcinogencity:  0.007
Eye Corrosion:  0.988
Eye Irritation:  0.927
Respiratory Toxicity:  0.474

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC471901

Natural Product ID:  NPC471901
Common Name*:   3-O-Acetyl-Lupeolic Acid
IUPAC Name:   (1R,3aR,5aR,5bR,7aR,8R,9S,11aR,11bR,13aR,13bR)-9-acetyloxy-3a,5a,5b,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-8-carboxylic acid
Synonyms:  
Standard InCHIKey:  DULLEXJVWYWBKQ-VDHVTXALSA-N
Standard InCHI:  InChI=1S/C32H50O4/c1-19(2)21-11-14-28(4)17-18-30(6)22(26(21)28)9-10-23-29(5)15-13-25(36-20(3)33)32(8,27(34)35)24(29)12-16-31(23,30)7/h21-26H,1,9-18H2,2-8H3,(H,34,35)/t21-,22+,23+,24+,25-,26+,28+,29+,30+,31+,32+/m0/s1
SMILES:  CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C(=O)O)OC(=O)C)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3289106
PubChem CID:   90644331
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33055 boswellia spp. Species Burseraceae Eukaryota n.a. n.a. n.a. PMID[24844534]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT136 Cell Line SK-N-SH Homo sapiens IC50 = 4100.0 nM PMID[465307]
NPT324 Individual Protein Cyclooxygenase-1 Ovis aries IC50 > 10000.0 nM PMID[465307]
NPT31 Individual Protein Cyclooxygenase-2 Homo sapiens IC50 > 10000.0 nM PMID[465307]
NPT956 Individual Protein Prostaglandin E synthase Homo sapiens Activity = 51.4 % PMID[465307]
NPT956 Individual Protein Prostaglandin E synthase Homo sapiens IC50 = 10000.0 nM PMID[465307]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 4100.0 nM PMID[465307]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC471901 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9884 High Similarity NPC287118
0.9884 High Similarity NPC471902
0.9884 High Similarity NPC473690
0.9767 High Similarity NPC475416
0.9647 High Similarity NPC4309
0.9535 High Similarity NPC213832
0.9535 High Similarity NPC57954
0.9419 High Similarity NPC471900
0.9318 High Similarity NPC160506
0.9302 High Similarity NPC269360
0.9302 High Similarity NPC264005
0.9302 High Similarity NPC33768
0.9294 High Similarity NPC98270
0.9205 High Similarity NPC169933
0.9186 High Similarity NPC12774
0.9186 High Similarity NPC2783
0.9176 High Similarity NPC475509
0.9121 High Similarity NPC327788
0.907 High Similarity NPC264317
0.907 High Similarity NPC294438
0.9059 High Similarity NPC471037
0.9011 High Similarity NPC205173
0.8977 High Similarity NPC474719
0.8977 High Similarity NPC146937
0.8977 High Similarity NPC16377
0.8925 High Similarity NPC472028
0.8901 High Similarity NPC78580
0.8901 High Similarity NPC184006
0.8901 High Similarity NPC23621
0.8876 High Similarity NPC271974
0.8876 High Similarity NPC220498
0.8876 High Similarity NPC247312
0.8864 High Similarity NPC134197
0.8851 High Similarity NPC201655
0.8837 High Similarity NPC5280
0.883 High Similarity NPC94906
0.8817 High Similarity NPC253586
0.8804 High Similarity NPC195715
0.8804 High Similarity NPC23241
0.8804 High Similarity NPC210214
0.8791 High Similarity NPC475061
0.8778 High Similarity NPC471896
0.875 High Similarity NPC168231
0.8737 High Similarity NPC75941
0.871 High Similarity NPC120708
0.8706 High Similarity NPC261616
0.8706 High Similarity NPC304194
0.8696 High Similarity NPC47853
0.8696 High Similarity NPC303863
0.8696 High Similarity NPC277399
0.8667 High Similarity NPC474889
0.8652 High Similarity NPC57469
0.8646 High Similarity NPC124544
0.8632 High Similarity NPC108371
0.8621 High Similarity NPC472743
0.8621 High Similarity NPC475726
0.8617 High Similarity NPC26413
0.8602 High Similarity NPC279974
0.8602 High Similarity NPC263135
0.8602 High Similarity NPC470229
0.8602 High Similarity NPC288906
0.8602 High Similarity NPC266431
0.8588 High Similarity NPC305835
0.8587 High Similarity NPC244356
0.8587 High Similarity NPC291373
0.8587 High Similarity NPC294263
0.8587 High Similarity NPC86368
0.8587 High Similarity NPC224060
0.8571 High Similarity NPC113989
0.8571 High Similarity NPC175628
0.8571 High Similarity NPC120840
0.8571 High Similarity NPC148414
0.8571 High Similarity NPC111585
0.8557 High Similarity NPC470310
0.8556 High Similarity NPC211162
0.8556 High Similarity NPC183374
0.8526 High Similarity NPC474092
0.8526 High Similarity NPC78427
0.8526 High Similarity NPC119036
0.8526 High Similarity NPC164349
0.8526 High Similarity NPC16911
0.8523 High Similarity NPC319909
0.8523 High Similarity NPC74595
0.8523 High Similarity NPC474482
0.8523 High Similarity NPC475745
0.8523 High Similarity NPC264665
0.8511 High Similarity NPC13949
0.8511 High Similarity NPC329910
0.8511 High Similarity NPC234564
0.8495 Intermediate Similarity NPC475118
0.8495 Intermediate Similarity NPC469982
0.8488 Intermediate Similarity NPC206735
0.8478 Intermediate Similarity NPC250753
0.8478 Intermediate Similarity NPC60755
0.8478 Intermediate Similarity NPC285184
0.8478 Intermediate Similarity NPC470590
0.8478 Intermediate Similarity NPC228784
0.8478 Intermediate Similarity NPC155120
0.8478 Intermediate Similarity NPC324341
0.8478 Intermediate Similarity NPC26888
0.8478 Intermediate Similarity NPC966
0.8478 Intermediate Similarity NPC288833
0.8478 Intermediate Similarity NPC282616
0.8478 Intermediate Similarity NPC77099
0.8462 Intermediate Similarity NPC30522
0.8462 Intermediate Similarity NPC474704
0.8462 Intermediate Similarity NPC474570
0.8462 Intermediate Similarity NPC471043
0.8462 Intermediate Similarity NPC475921
0.8444 Intermediate Similarity NPC252714
0.8438 Intermediate Similarity NPC180733
0.8438 Intermediate Similarity NPC287676
0.8438 Intermediate Similarity NPC41971
0.8438 Intermediate Similarity NPC37047
0.8427 Intermediate Similarity NPC292553
0.8421 Intermediate Similarity NPC469810
0.8409 Intermediate Similarity NPC473742
0.8404 Intermediate Similarity NPC470232
0.8404 Intermediate Similarity NPC473648
0.8384 Intermediate Similarity NPC265127
0.8372 Intermediate Similarity NPC192744
0.837 Intermediate Similarity NPC172361
0.837 Intermediate Similarity NPC86372
0.837 Intermediate Similarity NPC474728
0.8353 Intermediate Similarity NPC68828
0.8351 Intermediate Similarity NPC46848
0.8351 Intermediate Similarity NPC473514
0.8351 Intermediate Similarity NPC289148
0.8351 Intermediate Similarity NPC163963
0.8351 Intermediate Similarity NPC52899
0.8333 Intermediate Similarity NPC11035
0.8333 Intermediate Similarity NPC474793
0.8333 Intermediate Similarity NPC471038
0.8333 Intermediate Similarity NPC472738
0.8333 Intermediate Similarity NPC98236
0.8333 Intermediate Similarity NPC80590
0.8333 Intermediate Similarity NPC187545
0.8333 Intermediate Similarity NPC472505
0.8333 Intermediate Similarity NPC269396
0.8316 Intermediate Similarity NPC98874
0.8315 Intermediate Similarity NPC299963
0.8315 Intermediate Similarity NPC474233
0.8298 Intermediate Similarity NPC159410
0.8298 Intermediate Similarity NPC296164
0.8298 Intermediate Similarity NPC74751
0.8298 Intermediate Similarity NPC222047
0.8298 Intermediate Similarity NPC470385
0.8298 Intermediate Similarity NPC470386
0.8295 Intermediate Similarity NPC289486
0.8295 Intermediate Similarity NPC61107
0.828 Intermediate Similarity NPC471588
0.828 Intermediate Similarity NPC470230
0.828 Intermediate Similarity NPC198242
0.828 Intermediate Similarity NPC211403
0.828 Intermediate Similarity NPC6255
0.8265 Intermediate Similarity NPC286519
0.8265 Intermediate Similarity NPC246736
0.8265 Intermediate Similarity NPC475558
0.8265 Intermediate Similarity NPC275990
0.8265 Intermediate Similarity NPC88203
0.8265 Intermediate Similarity NPC304832
0.8265 Intermediate Similarity NPC473788
0.8265 Intermediate Similarity NPC214946
0.8265 Intermediate Similarity NPC76866
0.8265 Intermediate Similarity NPC148628
0.8261 Intermediate Similarity NPC293048
0.8261 Intermediate Similarity NPC59263
0.8261 Intermediate Similarity NPC130520
0.8261 Intermediate Similarity NPC61543
0.8261 Intermediate Similarity NPC77001
0.8261 Intermediate Similarity NPC225585
0.8261 Intermediate Similarity NPC116146
0.8261 Intermediate Similarity NPC24772
0.8261 Intermediate Similarity NPC270768
0.8261 Intermediate Similarity NPC127689
0.8261 Intermediate Similarity NPC121798
0.8261 Intermediate Similarity NPC234346
0.8261 Intermediate Similarity NPC263393
0.8261 Intermediate Similarity NPC253618
0.8256 Intermediate Similarity NPC63020
0.8247 Intermediate Similarity NPC475156
0.8247 Intermediate Similarity NPC473576
0.8242 Intermediate Similarity NPC474684
0.8242 Intermediate Similarity NPC46912
0.8242 Intermediate Similarity NPC142361
0.8242 Intermediate Similarity NPC162107
0.8242 Intermediate Similarity NPC4643
0.8235 Intermediate Similarity NPC246445
0.8229 Intermediate Similarity NPC158347
0.8229 Intermediate Similarity NPC476879
0.8229 Intermediate Similarity NPC476878
0.8218 Intermediate Similarity NPC88744
0.8211 Intermediate Similarity NPC148523
0.8211 Intermediate Similarity NPC184848
0.8211 Intermediate Similarity NPC98639
0.8211 Intermediate Similarity NPC69548
0.8211 Intermediate Similarity NPC474727
0.8202 Intermediate Similarity NPC245866
0.8202 Intermediate Similarity NPC471036
0.8202 Intermediate Similarity NPC291320

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC471901 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9318 High Similarity NPD8035 Phase 2
0.9318 High Similarity NPD8034 Phase 2
0.907 High Similarity NPD7520 Clinical (unspecified phase)
0.8298 Intermediate Similarity NPD7748 Approved
0.8041 Intermediate Similarity NPD7902 Approved
0.8023 Intermediate Similarity NPD6117 Approved
0.8 Intermediate Similarity NPD6399 Phase 3
0.7931 Intermediate Similarity NPD6116 Phase 1
0.7895 Intermediate Similarity NPD7515 Phase 2
0.7841 Intermediate Similarity NPD6115 Approved
0.7841 Intermediate Similarity NPD6697 Approved
0.7841 Intermediate Similarity NPD6118 Approved
0.7841 Intermediate Similarity NPD6114 Approved
0.7791 Intermediate Similarity NPD6113 Clinical (unspecified phase)
0.7732 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7732 Intermediate Similarity NPD7900 Approved
0.767 Intermediate Similarity NPD6675 Approved
0.767 Intermediate Similarity NPD5739 Approved
0.767 Intermediate Similarity NPD7128 Approved
0.767 Intermediate Similarity NPD6402 Approved
0.76 Intermediate Similarity NPD7638 Approved
0.7579 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7527 Intermediate Similarity NPD4786 Approved
0.7525 Intermediate Similarity NPD7639 Approved
0.7525 Intermediate Similarity NPD7640 Approved
0.7524 Intermediate Similarity NPD6899 Approved
0.7524 Intermediate Similarity NPD6881 Approved
0.7524 Intermediate Similarity NPD7320 Approved
0.75 Intermediate Similarity NPD6083 Phase 2
0.75 Intermediate Similarity NPD6084 Phase 2
0.75 Intermediate Similarity NPD5328 Approved
0.7477 Intermediate Similarity NPD8130 Phase 1
0.7455 Intermediate Similarity NPD7115 Discovery
0.7453 Intermediate Similarity NPD6372 Approved
0.7453 Intermediate Similarity NPD6373 Approved
0.7429 Intermediate Similarity NPD5697 Approved
0.7429 Intermediate Similarity NPD5701 Approved
0.7419 Intermediate Similarity NPD4788 Approved
0.7407 Intermediate Similarity NPD8297 Approved
0.7396 Intermediate Similarity NPD5737 Approved
0.7396 Intermediate Similarity NPD6672 Approved
0.7383 Intermediate Similarity NPD7290 Approved
0.7383 Intermediate Similarity NPD6883 Approved
0.7383 Intermediate Similarity NPD7102 Approved
0.7368 Intermediate Similarity NPD6684 Approved
0.7368 Intermediate Similarity NPD3618 Phase 1
0.7368 Intermediate Similarity NPD7146 Approved
0.7368 Intermediate Similarity NPD5330 Approved
0.7368 Intermediate Similarity NPD7334 Approved
0.7368 Intermediate Similarity NPD7521 Approved
0.7368 Intermediate Similarity NPD6409 Approved
0.7356 Intermediate Similarity NPD4809 Clinical (unspecified phase)
0.7356 Intermediate Similarity NPD4808 Clinical (unspecified phase)
0.7347 Intermediate Similarity NPD6079 Approved
0.7339 Intermediate Similarity NPD8133 Approved
0.7315 Intermediate Similarity NPD6869 Approved
0.7315 Intermediate Similarity NPD6650 Approved
0.7315 Intermediate Similarity NPD6847 Approved
0.7315 Intermediate Similarity NPD6617 Approved
0.7315 Intermediate Similarity NPD6649 Approved
0.7312 Intermediate Similarity NPD3667 Approved
0.73 Intermediate Similarity NPD5695 Phase 3
0.729 Intermediate Similarity NPD6014 Approved
0.729 Intermediate Similarity NPD6013 Approved
0.729 Intermediate Similarity NPD6012 Approved
0.7283 Intermediate Similarity NPD7525 Registered
0.7255 Intermediate Similarity NPD5696 Approved
0.7248 Intermediate Similarity NPD6882 Approved
0.7216 Intermediate Similarity NPD6903 Approved
0.7196 Intermediate Similarity NPD6011 Approved
0.7174 Intermediate Similarity NPD7645 Phase 2
0.7172 Intermediate Similarity NPD6411 Approved
0.7159 Intermediate Similarity NPD6081 Approved
0.7159 Intermediate Similarity NPD5777 Approved
0.7157 Intermediate Similarity NPD4755 Approved
0.7156 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7129 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD3699 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD3700 Clinical (unspecified phase)
0.7119 Intermediate Similarity NPD7736 Approved
0.7111 Intermediate Similarity NPD3702 Approved
0.71 Intermediate Similarity NPD4202 Approved
0.7059 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD5222 Approved
0.7059 Intermediate Similarity NPD5221 Approved
0.7059 Intermediate Similarity NPD4697 Phase 3
0.7048 Intermediate Similarity NPD7632 Discontinued
0.7019 Intermediate Similarity NPD5286 Approved
0.7019 Intermediate Similarity NPD4700 Approved
0.7019 Intermediate Similarity NPD4696 Approved
0.7019 Intermediate Similarity NPD5285 Approved
0.7011 Intermediate Similarity NPD5360 Phase 3
0.7011 Intermediate Similarity NPD5361 Clinical (unspecified phase)
0.701 Intermediate Similarity NPD6098 Approved
0.701 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD7637 Suspended
0.6991 Remote Similarity NPD8295 Clinical (unspecified phase)
0.699 Remote Similarity NPD5173 Approved
0.6979 Remote Similarity NPD3666 Approved
0.6979 Remote Similarity NPD3668 Phase 3
0.6979 Remote Similarity NPD3133 Approved
0.6979 Remote Similarity NPD3665 Phase 1
0.6977 Remote Similarity NPD4224 Phase 2
0.697 Remote Similarity NPD5764 Clinical (unspecified phase)
0.697 Remote Similarity NPD4753 Phase 2
0.697 Remote Similarity NPD6101 Approved
0.697 Remote Similarity NPD6673 Approved
0.697 Remote Similarity NPD6080 Approved
0.697 Remote Similarity NPD6904 Approved
0.6957 Remote Similarity NPD6319 Approved
0.6923 Remote Similarity NPD4225 Approved
0.6923 Remote Similarity NPD3703 Phase 2
0.6923 Remote Similarity NPD8328 Phase 3
0.6917 Remote Similarity NPD7319 Approved
0.6903 Remote Similarity NPD6274 Approved
0.6903 Remote Similarity NPD6868 Approved
0.6891 Remote Similarity NPD8293 Discontinued
0.6887 Remote Similarity NPD5211 Phase 2
0.6887 Remote Similarity NPD5225 Approved
0.6887 Remote Similarity NPD5226 Approved
0.6887 Remote Similarity NPD5224 Approved
0.6887 Remote Similarity NPD4633 Approved
0.6881 Remote Similarity NPD5345 Clinical (unspecified phase)
0.687 Remote Similarity NPD7100 Approved
0.687 Remote Similarity NPD7101 Approved
0.6864 Remote Similarity NPD7492 Approved
0.6854 Remote Similarity NPD4245 Approved
0.6854 Remote Similarity NPD4244 Approved
0.6854 Remote Similarity NPD4789 Approved
0.6852 Remote Similarity NPD6008 Approved
0.6822 Remote Similarity NPD5174 Approved
0.6822 Remote Similarity NPD5175 Approved
0.6818 Remote Similarity NPD8132 Clinical (unspecified phase)
0.681 Remote Similarity NPD6054 Approved
0.681 Remote Similarity NPD6059 Approved
0.6807 Remote Similarity NPD6616 Approved
0.6807 Remote Similarity NPD7507 Approved
0.6792 Remote Similarity NPD5223 Approved
0.6789 Remote Similarity NPD6412 Phase 2
0.6783 Remote Similarity NPD6335 Approved
0.6771 Remote Similarity NPD4223 Phase 3
0.6771 Remote Similarity NPD4221 Approved
0.6768 Remote Similarity NPD3573 Approved
0.6759 Remote Similarity NPD5141 Approved
0.6757 Remote Similarity NPD4634 Approved
0.6752 Remote Similarity NPD6909 Approved
0.6752 Remote Similarity NPD6908 Approved
0.675 Remote Similarity NPD7078 Approved
0.6742 Remote Similarity NPD3698 Phase 2
0.6742 Remote Similarity NPD4267 Clinical (unspecified phase)
0.6739 Remote Similarity NPD6942 Approved
0.6739 Remote Similarity NPD7339 Approved
0.6735 Remote Similarity NPD5329 Approved
0.6726 Remote Similarity NPD4632 Approved
0.67 Remote Similarity NPD5208 Approved
0.6699 Remote Similarity NPD6001 Approved
0.6697 Remote Similarity NPD4767 Approved
0.6697 Remote Similarity NPD4768 Approved
0.6696 Remote Similarity NPD6317 Approved
0.6695 Remote Similarity NPD6370 Approved
0.6667 Remote Similarity NPD4754 Approved
0.6667 Remote Similarity NPD5284 Approved
0.6667 Remote Similarity NPD5279 Phase 3
0.6667 Remote Similarity NPD3171 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5693 Phase 1
0.6667 Remote Similarity NPD6050 Approved
0.6667 Remote Similarity NPD5281 Approved
0.6638 Remote Similarity NPD6314 Approved
0.6638 Remote Similarity NPD6313 Approved
0.6635 Remote Similarity NPD4629 Approved
0.6635 Remote Similarity NPD5210 Approved
0.6634 Remote Similarity NPD6051 Approved
0.6634 Remote Similarity NPD7285 Clinical (unspecified phase)
0.6633 Remote Similarity NPD4197 Approved
0.661 Remote Similarity NPD6016 Approved
0.661 Remote Similarity NPD6015 Approved
0.6602 Remote Similarity NPD5778 Approved
0.6602 Remote Similarity NPD5779 Approved
0.6598 Remote Similarity NPD4752 Clinical (unspecified phase)
0.6593 Remote Similarity NPD4758 Discontinued
0.6577 Remote Similarity NPD5128 Approved
0.6577 Remote Similarity NPD4730 Approved
0.6577 Remote Similarity NPD4729 Approved
0.6569 Remote Similarity NPD5692 Phase 3
0.6555 Remote Similarity NPD5988 Approved
0.6552 Remote Similarity NPD6009 Approved
0.6542 Remote Similarity NPD8418 Phase 2
0.6526 Remote Similarity NPD3671 Phase 1
0.6526 Remote Similarity NPD3617 Approved
0.6526 Remote Similarity NPD5784 Clinical (unspecified phase)
0.6526 Remote Similarity NPD5364 Discontinued
0.6525 Remote Similarity NPD8377 Approved
0.6525 Remote Similarity NPD8294 Approved
0.6518 Remote Similarity NPD4061 Clinical (unspecified phase)
0.6505 Remote Similarity NPD5694 Approved
0.65 Remote Similarity NPD4689 Approved
0.65 Remote Similarity NPD7604 Phase 2
0.65 Remote Similarity NPD5205 Approved
0.65 Remote Similarity NPD4688 Approved
0.65 Remote Similarity NPD4138 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data